Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 335-339

  Wong, Kelvin Kin Kwan ^a   Ngo, Jacky Chi Ki ^b   Liu, Sijie ^a,c   Lin, Huang quan ^a   Hu, Chun ^c   Shaw, Pang Chui ^b   Wan, David Chi Cheong ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Autodock; Cholinesterase; Cryptotanshinone; Dihydrotanshinone

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CRYPTOTANSHINONE; DIHYDROTANSHINONE; DITERPENE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG INHIBITION; DRUG SPECIFICITY; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; HYDROPHOBICITY; MOLECULAR DOCKING;

SALVIA MILTIORRHIZA;

EID: 77955511441     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.03.026     Document Type: Article

References (18)

1. Giacobini E. Cholinergic function and Alzheimer's disease. Int. J. Geriatr. Psychiatry 2003, 18(Suppl. 1):S1-S5.
2. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 1978, 4(4):273-277.
3. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 1978, 2(6150):1457-1459.
4. Mukherjee P.K., Kumar V., Mal M., Houghton P.J. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007, 14(4):289-300.
5. Howes M.J., Houghton P.J. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol. Biochem. Behav. 2003, 75(3):513-527.
6. Thirugnanasampandan R., Jayakumar R., Narmatha Bai V., Martin E., Rajendra Prasad K.J. Antiacetylcholinesterase and antioxidant ent-Kaurene diterpenoid, melissoidesin from Isodon wightii (Bentham) H. Hara. Nat. Prod. Res. 2008, 22(8):681-688.
7. Ren Y., Houghton P.J., Hider R.C., Howes M.J. Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med. 2004, 70(3):201-204.
8. Kim D.H., Jeon S.J., Jung J.W., Lee S., Yoon B.H., Shin B.Y., Son K.H., Cheong J.H., Kim Y.S., Kang S.S., Ko K.H., Ryu J.H. Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice. Eur. J. Pharmacol. 2007, 574(2-3):140-147.
9. Mei Z., Zhang F., Tao L., Zheng W., Cao Y., Wang Z., Tang S., Le K., Chen S., Pi R., Liu P. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neurosci. Lett. 2009, 452(2):90-95.
10. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
11. Rosenberry T.L., Johnson J.L., Cusack B., Thomas J.L., Emani S., Venkatasubban K.S. Interactions between the peripheral site and the acylation site in acetylcholinesterase. Chem. Biol. Interact. 2005, 157-158:181-189.
12. Stojan J., Golicnik M., Froment M.T., Estour F., Masson P. Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion. Eur. J. Biochem. 2002, 269(4):1154-1161.
13. Ariel N., Ordentlich A., Barak D., Bino T., Velan B., Shafferman A. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors. Biochem. J. 1998, 335(Pt 1):95-102.
14. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991, 253(5022):872-879.
15. Zhang Y., Kua J., McCammon J.A. Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study. J. Am. Chem. Soc. 2002, 124(35):10572-10577.
16. Radic Z., Pickering N.A., Vellom D.C., Camp S., Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry (Mosc.) 1993, 32(45):12074-12084.
17. Khalid A., Zaheer ul H., Anjum S., Khan M.R., Atta ur R., Choudhary M.I. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases. Bioorg. Med. Chem. 2004, 12(9):1995-2003.
18. Kishibayashi N., Ishii A., Karasawa A. Inhibitory effects of KW-5092, a novel gastroprokinetic agent, on the activity of acetylcholinesterase in guinea pig ileum. Jpn. J. Pharmacol. 1994, 66(4):397-403.